AMBER SCHAEFER: Open Payments
NPI 1841934908 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 26 payments from 12 companies in 2025. Trend: 2023 $123 · 2024 $140 · 2025 $657
Food & beverage: $577Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Janssen Biotech, Inc. | 2 | $103 |
| UCB, Inc. | 3 | $94 |
| GENZYME CORPORATION | 1 | $36 |
| Journey Medical Corporation | 1 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: COSENTYX, TREMFYA, Bimzelx, RINVOQ, SKYRIZI, DUPIXENT, Winlevi, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
